SKIN ELEMENTS LIMITED — Share Issue/Capital Change 2025

Mar 11, 2025

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

SKIN ELEMENTS LIMITED

Announcement Type

New announcement

Date of this announcement

Wednesday March 12, 2025

The +securities to be quoted are: Other

Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.

Shares represent oversubscriptions on its non renounceable rights issue prospectus dated 19 Dec 2024 and reported to ASX as oversubscriptions in its announcement dated 7 March 2025 titled entitlement issue results

Total number of +securities to be quoted

ASX +security		Number of +securities to
code	Security description	be quoted	Issue date
SKN	ORDINARY FULLY PAID	4,497,470	07/03/2025

Refer to next page for full details of the announcement

Appendix 2A - Application for quotation of securities

1 / 6

Appendix 2A - Application for quotation of securities

Part 1 - Entity and announcement details

==> picture [21 x 22] intentionally omitted <==

1.1 Name of entity

SKIN ELEMENTS LIMITED

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type

ACN

Registration number

608047794

1.3 ASX issuer code

SKN

1.4 The announcement is

New announcement

1.5 Date of this announcement

12/3/2025

Appendix 2A - Application for quotation of securities

2 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Type of Issue

2.1 The +securities to be quoted are: Other

Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue.

2.2 The +class of +securities to be quoted is:

Additional +securities in a class that is already quoted on ASX ("existing class")

2.3c Have these +securities been offered under a +disclosure document or +PDS? No

2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B

Shares represent oversubscriptions on its non renounceable rights issue prospectus dated 19 Dec 2024 and reported to ASX as oversubscriptions in its announcement dated 7 March 2025 titled entitlement issue results

2.4 Any on-sale of the +securities to be quoted within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of: The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f)

Appendix 2A - Application for quotation of securities

3 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Appendix 2A - Application for quotation of securities	Appendix 2A - Application for quotation of securities
Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an
Appendix 3B
Additional +securities to be quoted in an existing class
ASX +security code and description
SKN : ORDINARY FULLY PAID
Issue date
7/3/2025
Will the +securities to be quoted rank equally in all respects from their issue date with the
existing issued +securities in that class?
Yes
Issue details
Number of +securities to be quoted
4,497,470
Are the +securities being issued for a cash consideration?
Yes
In what currency is the cash consideration being paid?	What is the issue price per +security?
AUD - Australian Dollar	AUD 0.00300000
Any other information the entity wishes to provide about the +securities to be quoted The purpose(s) for which the entity is issuing the securities
Other
Please provide additional details applied prorata in line with the rights issue prospectus clause 3.1

Appendix 2A - Application for quotation of securities

4 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 4 - Issued capital following quotation

Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise:

The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application)

+securities subject of this application)
	Total number of
ASX +security code and description	+securities on issue
SKNOD : OPTION EXPIRING 31-MAY-2026	133,351,198
SKN : ORDINARY FULLY PAID	1,031,880,782

4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX)

	Total number of
ASX +security code and description	+securities on issue
SKNAS : OPTION EXPIRING 31-OCT-2025 EX $0.05	28,000,000
SKNAU : PERFORMANCE SHARES CLASS A	100,000,000
SKNAV : PERFORMANCE SHARES CLASS B	62,000,000
SKNAX : OPTION EXPIRING 21-FEB-2028 EX $0.01	171,230,552

Appendix 2A - Application for quotation of securities

5 / 6

Appendix 2A - Application for quotation of securities

==> picture [21 x 22] intentionally omitted <==

Part 5 - Other Listing Rule requirements

5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? No

5.2 Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1? No

5.2b Are any of the +securities being issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? Yes

5.2b.1 How many +securities are being issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? 4497470

5.2c Are any of the +securities being issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? No

Appendix 2A - Application for quotation of securities

6 / 6